Experiment 1192582

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeSC
OrganismStreptococcus pyogenes (STREPTOCOCCACEAE)
CitationYAGI,Y: YAGI,S:. (1988). IMMINOTHERAPY OF PATIENTS WITH TERMINAL-STAGE MALIGNANT TUMORS WITH AN IMMUNOPOTENTIATOR OK-432 - A COMPARISON OF SU-PS TEST-RESPONDING AND-NONRESPONDING PATIENTS.. 10(4)
Amount utilized
Compound isolated
DiseaseTESTED IN PATIENTS WITH TERMINAL TUMORS.
Dose amountVAR
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE